|
1
|
Carew RM, Wang B and Kantharidis P: The
role of EMT in renal fibrosis. Cell Tissue Res. 347:103–116. 2012.
View Article : Google Scholar
|
|
2
|
Zeisberg M and Kalluri R: The role of
epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med
(Berl). 82:175–181. 2004. View Article : Google Scholar
|
|
3
|
Yang J and Liu Y: Dissection of key events
in tubular epithelial to myofibroblast transition and its
implications in renal interstitial fibrosis. Am J Pathol.
159:1465–1475. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Caramel J, Papadogeorgakis E, Hill L, et
al: A switch in the expression of embryonic EMT-inducers drives the
development of malignant melanoma. Cancer Cell. 24:466–480. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simic P, Williams EO, Bell EL, Gong JJ,
Bonkowski M and Guarente L: SIRT1 suppresses the
epithelial-to-mesenchymal transition in cancer metastasis and organ
fibrosis. Cell Rep. 3:1175–1186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guarino M, Tosoni A and Nebuloni M: Direct
contribution of epithelium to organ fibrosis:
epithelial-mesenchymal transition. Hum Pathol. 40:1365–1376. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu YN, Abou-Kheir W, Yin JJ, et al:
Critical and reciprocal regulation of KLF4 and SLUG in transforming
growth factor beta-initiated prostate cancer epithelial-mesenchymal
transition. Mol Cell Biol. 32:941–953. 2012. View Article : Google Scholar :
|
|
8
|
Liu Y: Epithelial to mesenchymal
transition in renal fibrogenesis: pathologic significance,
molecular mechanism, and therapeutic intervention. J Am Soc
Nephrol. 15:1–12. 2004. View Article : Google Scholar
|
|
9
|
Tiwari N, Meyer-Schaller N, Arnold P, et
al: Klf4 is a transcriptional regulator of genes critical for EMT,
including Jnk1 (Mapk8). PLoS One. 8:e573292013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui J, Shi M, Quan M and Xie K: Regulation
of EMT by KLF4 in gastrointestinal cancer. Curr Cancer Drug
Targets. 13:986–995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Wang J, Xiao W, et al: Epigenetic
alterations of Kruppel-like factor 4 and its tumor suppressor
function in renal cell carcinoma. Carcinogenesis. 34:2262–2270.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dressler GR: Epigenetics, development, and
the kidney. J Am Soc Nephrol. 19:2060–2067. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smyth LJ, McKay GJ, Maxwell AP and
McKnight AJ: DNA hypermethylation and DNA hypomethylation is
present at different loci in chronic kidney disease. Epigenetics.
9:366–376. 2014. View Article : Google Scholar :
|
|
14
|
Sanders YY, Tollefsbol TO, Varisco BM and
Hagood JS: Epigenetic regulation of thy-1 by histone deacetylase
inhibitor in rat lung fibroblasts. Am J Respir Cell Mol Biol.
45:16–23. 2011. View Article : Google Scholar :
|
|
15
|
Denby L, Ramdas V, Lu R, et al:
MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc
Nephrol. 25:65–80. 2014. View Article : Google Scholar :
|
|
16
|
Zarjou A, Yang S, Abraham E, Agarwal A and
Liu G: Identification of a microRNA signature in renal fibrosis:
role of miR-21. Am J Physiol Renal Physiol. 301:F793–F801. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bechtel W, McGoohan S, Zeisberg EM, et al:
Methylation determines fibroblast activation and fibrogenesis in
the kidney. Nat Med. 16:544–550. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Kong J, Deb DK, Chang A and Li
YC: Vitamin D receptor attenuates renal fibrosis by suppressing the
reninangiotensin system. J Am Soc Nephrol. 21:966–973. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li LC and Dahiya R: MethPrimer: designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun Y, Wang L, Zhou Y, Mao X and Deng X:
Cloning and characterization of the human trefoil factor 3 gene
promoter. PLoS One. 9:e955622014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei S, Xiong M, Zhan DQ, et al: Ku80
functions as a tumor suppressor in hepatocellular carcinoma by
inducing S-phase arrest through a p53-dependent pathway.
Carcinogenesis. 33:538–547. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Galichon P and Hertig A: Epithelial to
mesenchymal transition as a biomarker in renal fibrosis: are we
ready for the bedside? Fibrogenesis Tissue Repair. 4:112011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Strutz F, Okada H, Lo CW, et al:
Identification and characterization of a fibroblast marker: FSP1. J
Cell Biol. 130:393–405. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iwano M, Plieth D, Danoff TM, Xue C, Okada
H and Neilson EG: Evidence that fibroblasts derive from epithelium
during tissue fibrosis. J Clin Invest. 110:341–350. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lei X, Wang L, Yang J and Sun LZ: TGFbeta
signaling supports survival and metastasis of endometrial cancer
cells. Cancer Manag Res. 2009:15–24. 2009.PubMed/NCBI
|
|
26
|
Chen YX, Li Y, Wang WM, et al:
Phosphoproteomic study of human tubular epithelial cell in response
to transforming growth factor-beta-1-induced
epithelial-to-mesenchymal transition. Am J Nephrol. 31:24–35. 2010.
View Article : Google Scholar
|
|
27
|
Yang J and Liu Y: Blockage of tubular
epithelial to myofibroblast transition by hepatocyte growth factor
prevents renal interstitial fibrosis. J Am Soc Nephrol. 13:96–107.
2002.
|
|
28
|
Kanlaya R, Sintiprungrat K and
Thongboonkerd V: Secreted products of macrophages exposed to
calcium oxalate crystals induce epithelial mesenchymal transition
of renal tubular cells via RhoA-dependent TGF-beta1 pathway. Cell
Biochem Biophys. 67:1207–1215. 2013. View Article : Google Scholar
|
|
29
|
Forino M, Torregrossa R, Ceol M, et al:
TGFbeta1 induces epithelial-mesenchymal transition, but not
myofibroblast transdifferentiation of human kidney tubular
epithelial cells in primary culture. Int J Exp Pathol. 87:197–208.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang B, Pi L, Chen C, et al: WT1 and Pax2
re-expression is required for epithelial-mesenchymal transition in
5/6 nephrectomized rats and cultured kidney tubular epithelial
cells. Cells Tissues Organs. 195:296–312. 2012. View Article : Google Scholar
|
|
31
|
Gu L, Gao Q, Ni L, Wang M and Shen F:
Fasudil inhibits epithelial-myofibroblast transdifferentiation of
human renal tubular epithelial HK-2 cells induced by high glucose.
Chem Pharm Bull (Tokyo). 61:688–694. 2013. View Article : Google Scholar
|
|
32
|
Han WQ, Zhu Q, Hu J, Li PL, Zhang F and Li
N: Hypoxia-inducible factor prolyl-hydroxylase-2 mediates
transforming growth factor beta 1-induced epithelial-mesenchymal
transition in renal tubular cells. Biochim Biophys Acta.
1833:1454–1462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bian EB, Huang C, Ma TT, et al:
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell
activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol.
264:13–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bian EB, Huang C, Wang H, et al:
Repression of Smad7 mediated by DNMT1 determines hepatic stellate
cell activation and liver fibrosis in rats. Toxicol Lett.
224:175–185. 2014. View Article : Google Scholar
|
